Logo
SubscribeSign In
LeaderPortfolio
Billionaire Profile
Katharina von Baumbach
Global Rank
#669

Image: Public domain | via Wikimedia Commons

Katharina von Baumbach

CEO, Boehringer Ingelheim
DE
Real-Time Net Worth
$5.7B
As of December 2025
Age
25
Source
Pharma
Industry
healthcare
Citizenship
DE

Biography

Katharina von Baumbach, born in Germany on October 2, 1999, is a prominent figure in the pharmaceutical industry, recognized for her inherited wealth from Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. With a net worth estimated at $5.7 billion, Katharina is among the youngest billionaires in the world. Her wealth source is rooted in the pharma industry, reflecting her family's long-standing involvement and significant stake in Boehringer Ingelheim. Despite her substantial wealth, specific details about her career and active executive roles are not widely available, with her primary recognition stemming from her status as an heiress.

Wealth Over Time

In-Depth Profile

Early Life

Katharina von Baumbach was born in Germany on October 2, 1999. She is part of the von Baumbach family, deeply connected to Boehringer Ingelheim, a leading pharmaceutical company. Details about her early life and educational background are not widely available. Katharina currently resides in Ingelheim, Germany, where the Boehringer Ingelheim headquarters are located.

Rise to Success

Katharina's wealth comes from her inheritance of a stake in Boehringer Ingelheim. The company, founded in 1885, has grown to become the world's largest privately-owned pharmaceutical company. Katharina is one of the younger heirs, and as of 2024, she is 25 years old. Her family's stake in Boehringer Ingelheim is significant, contributing to her substantial net worth.

Key Business Strategies

While Katharina is not known to hold an active executive role in the company, the success of Boehringer Ingelheim, which underlies her wealth, stems from key strategies focused on pharmaceutical innovation. The company's focus includes research and development in human and animal health. The company also employs over 53,000 people and has a presence in 130 markets.

Philanthropy

Specific details about Katharina von Baumbach's philanthropic activities are not readily available in the search results.